{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:13:11Z","timestamp":1773342791950,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/29\/B\/NZ7\/00285"],"award-info":[{"award-number":["2018\/29\/B\/NZ7\/00285"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109209","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:01:15Z","timestamp":1762383675000},"page":"109209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Purine-2,6-dione-based multitarget-directed ligands inhibiting PDE\/TRPA1\/CHIT1 as a new approach for the treatment of COPD"],"prefix":"10.1016","volume":"167","author":[{"given":"Gra\u017cyna","family":"Ch\u0142o\u0144-Rzepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"W\u00f3jcik-Pszczo\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marietta","family":"\u015alusarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Gawalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Wi\u0119ckowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata","family":"Gryz\u0142o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Kazek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur","family":"\u015awierczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Pociecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"G\u0142uch-Lutwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mordyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Piska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Koczurkiewicz-Adamczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Kocot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Kubacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szczepan","family":"Mogilski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109209_bb0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"Adeloye","year":"2022","journal-title":"The Lancet Respiratory"},{"issue":"25","key":"10.1016\/j.bioorg.2025.109209_bb0015","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMc1914437","article-title":"Update on the pathogenesis of COPD","volume":"381","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109209_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001550","article-title":"Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort","volume":"10","author":"Wang","year":"2023","journal-title":"BMJ Open Respir. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109209_bb0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajpath.2013.09.007","article-title":"New insights into mechanisms controlling the NLRP3 Inflammasome and its role in lung disease","volume":"184","author":"De Nardo","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109209_bb0030","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.jmedchem.8b01520","article-title":"Targeted treatments for chronic obstructive pulmonary disease (COPD) using low-molecular-weight drugs (LMWDs)","volume":"62","author":"Ti","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109209_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: a review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0045","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1165\/rcmb.2017-0294OC","article-title":"PDE8 is expressed in human airway smooth muscle and selectively regulates cAMP signaling by \u03b22-adrenergic receptors and adenylyl cyclase 6","volume":"58","author":"Johnstone","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109209_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2019.02.002","article-title":"Phosphodiesterases as therapeutic targets for respiratory diseases","volume":"197","author":"Zuo","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0055","first-page":"301","article-title":"Research Progress on TRPA1 in diseases","volume":"256","author":"Li","year":"2023","journal-title":"The Journal of Membrane Biology 2023 256:4"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0060","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201637","article-title":"A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment","volume":"218","author":"Balestrini","year":"2021","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00210-015-1088-3","article-title":"TRPA1 as a drug target\u2014promise and challenges","volume":"388","author":"Chen","year":"2015","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109209_bb0070","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0900591106","article-title":"A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma","volume":"106","author":"Caceres","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109209_bb0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1165\/rcmb.2022-0159OC","article-title":"An inhibitory function of TRPA1 channels in TGF-\u03b21\u2013driven fibroblast-to-Myofibroblast differentiation","volume":"68","author":"Geiger","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109209_bb0080","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.3390\/ijms22136966","article-title":"Chitinases and Chitinase-like proteins as therapeutic targets in inflammatory diseases, with a special focus on inflammatory bowel diseases","volume":"22","author":"Mazur","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"156","key":"10.1016\/j.bioorg.2025.109209_bb0085","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0143-2019","article-title":"Chitotriosidase: a marker and modulator of lung disease","volume":"29","author":"Chang","year":"2020","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109209_bb0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000513296","article-title":"Chitinase-induced airway Hyperreactivity and inflammation in a mouse model of nonallergic asthma","volume":"182","author":"Weber-Chrysochoou","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109209_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/acs.jmedchem.7b01051","article-title":"Targeting acidic mammalian chitinase is effective in animal model of asthma","volume":"61","author":"Mazur","year":"2018","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109209_bb0100","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1021\/acs.jmedchem.9b00681","article-title":"Development of dual Chitinase inhibitors as potential new treatment for respiratory system diseases","volume":"62","author":"Mazur","year":"2019","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109209_bb0105","doi-asserted-by":"crossref","first-page":"15527","DOI":"10.1021\/acs.jmedchem.0c01179","article-title":"Discovery of OATD-01, a first-in-class Chitinase inhibitor as potential new therapeutics for idiopathic pulmonary fibrosis","volume":"63","author":"Koralewski","year":"2020","journal-title":"J. Med. Chem."},{"issue":"suppl","key":"10.1016\/j.bioorg.2025.109209_bb0110","first-page":"67","article-title":"Multicenter, randomized, double-blind, phase 2 study to assess the efficacy and safety of OATD-01, an oral inhibitor of chitinase-1 for the treatment of active pulmonary sarcoidosis","volume":"62","author":"Zas\u0142ona","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109209_bb0115","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.chembiol.2005.07.009","article-title":"Methylxanthine drugs are Chitinase inhibitors: investigation of inhibition and binding modes","volume":"12","author":"Rao","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109209_bb0120","doi-asserted-by":"crossref","unstructured":"D. Semotiuk, O. Tolokh, and N. Rudnitska, \u201cTreatment of sarcoidosis \u2013 pentoxifylline,\u201d Eur. Respir. J., vol. 54, no. suppl 63, p. PA1958, Nov. 2019, doi:https:\/\/doi.org\/10.1183\/13993003.CONGRESS-2019.PA1958.","DOI":"10.1183\/13993003.congress-2019.PA1958"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109209_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-021-01396-8","article-title":"Therapeutic effects of pentoxifylline on invasive pulmonary aspergillosis in immunosuppressed mice","volume":"21","author":"Feng","year":"2021","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.bioorg.2025.109209_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172779","article-title":"Novel phosphodiesterases inhibitors from the group of purine-2,6-dione derivatives as potent modulators of airway smooth muscle cell remodelling","volume":"865","author":"W\u00f3jcik-Pszczo\u0142a","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109209_bb0135","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.3390\/ijms21114008","article-title":"A novel, Pan-PDE inhibitor exerts anti-fibrotic effects in human lung fibroblasts via inhibition of TGF-\u03b2 signaling and activation of cAMP\/PKA signaling","volume":"21","author":"W\u00f3jcik-Pszczo\u0142a","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109209_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105409","article-title":"Synthesis and in vitro evaluation of anti-inflammatory, antioxidant, and anti-fibrotic effects of new 8-aminopurine-2,6-dione-based phosphodiesterase inhibitors as promising anti-asthmatic agents","volume":"117","author":"W\u00f3jcik-Pszczo\u0142a","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0145","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/ph15040423","article-title":"Pan-phosphodiesterase inhibitors attenuate TGF-\u03b2-induced pro-fibrotic phenotype in alveolar epithelial type II cells by downregulating Smad-2 phosphorylation","volume":"15","author":"W\u00f3jcik-Pszczo\u0142a","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109209_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116318","article-title":"In silico and in vitro ADME-Tox analysis and in vivo pharmacokinetic study of representative pan-PDE inhibitors from the group of 7,8-disubstituted derivatives of 1,3-dimethyl-7H-purine-2,6-dione","volume":"457","author":"W\u00f3jcik-Pszczo\u0142a","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109209_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110264","article-title":"Inhaled pan-phosphodiesterase inhibitors ameliorate ovalbumin-induced airway inflammation and remodeling in murine model of allergic asthma","volume":"119","author":"W\u00f3jcik-Pszczo\u0142a","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.109209_bb0160","first-page":"945","article-title":"Purines","volume":"16","author":"Seela","year":"2003","journal-title":"ScienceSynthesis"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109209_bb0165","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3109\/14756366.2015.1088844","article-title":"Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT\/D receptor agents with potential antipsychotic activity","volume":"31","author":"Ch\u0142o\u0144-Rzepa","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109209_bb0170","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm00156a032","article-title":"Antiinflammatory activity of substituted 6-hydroxypyrimido[2,1-f]purine-2,4,8(1H,3H,9H)-triones. Atypical nonsteroidal antiinflammatory agents","volume":"29","author":"Blythin","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109209_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2018.01.068","article-title":"Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4\/7 inhibitors with potential anti-inflammatory activity: design, synthesis and biological evaluation","volume":"146","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109209_bb0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejmech.2018.09.021","article-title":"Novel amide derivatives of 1,3-dimethyl-2,6-dioxopurin-7-yl-alkylcarboxylic acids as multifunctional TRPA1 antagonists and PDE4\/7 inhibitors: a new approach for the treatment of pain","volume":"158","author":"Ch\u0142o\u0144-Rzepa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109209_bb0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01180116","article-title":"Synthesis, crystal and molecular structure of 1,3-dimethyl-10-benzyl-2,4,9-trioxo-1,3,6,7,8,10-hexahydro-1,3-diazepino-[2,1-f]-purine","volume":"20","author":"Karolak-Wojciechowska","year":"1990","journal-title":"J. Cryst. Spectrosc."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0190","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201637","article-title":"A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment","volume":"218","author":"Balestrini","year":"2021","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109209_bb0195","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1165\/rcmb.2017-0427ED","article-title":"PDE8: a novel target in airway smooth muscle","volume":"58","author":"Zuo","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"48","key":"10.1016\/j.bioorg.2025.109209_bb0200","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1021\/bi801487x","article-title":"Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity","volume":"47","author":"Wang","year":"2008","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109209_bb0205","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens \u03b12-adrenoceptor\u2013mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109209_bb0210","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1021\/acs.jmedchem.0c02023","article-title":"Tetrahydrofuran-based transient receptor potential Ankyrin 1 (TRPA1) antagonists: ligand-based discovery, activity in a rodent asthma model, and mechanism-of-action via cryogenic Electron microscopy","volume":"64","author":"Terrett","year":"2021","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109209_bb0215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jmb.2004.01.040","article-title":"Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and Rolipram","volume":"337","author":"Xu","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109209_bb0220","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1021\/acs.jmedchem.0c01573","article-title":"Rational design of 2-Chloroadenine derivatives as highly selective phosphodiesterase 8A inhibitors","volume":"63","author":"Huang","year":"2020","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109209_bb0225","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/resp.12841","article-title":"Airway remodelling in COPD: it\u2019s not asthma!","volume":"21","author":"Jones","year":"2016","journal-title":"Respirology"},{"issue":"158","key":"10.1016\/j.bioorg.2025.109209_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/16000617.0124-2019","article-title":"Extracellular matrix remodelling in COPD","volume":"29","author":"Karakioulaki","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bioorg.2025.109209_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114218","article-title":"In vitro human cell-based models to study airway remodeling in asthma","volume":"159","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109209_bb0240","doi-asserted-by":"crossref","first-page":"1700202","DOI":"10.1183\/13993003.00202-2017","article-title":"Metabolic re-patterning in COPD airway smooth muscle cells","volume":"50","author":"Michaeloudes","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109209_bb0245","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/bph.13512","article-title":"Novel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility","volume":"173","author":"Venkatasamy","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109209_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.750","article-title":"The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease","volume":"10","author":"Wu","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.bioorg.2025.109209_bb0255","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.2147\/JIR.S324323","article-title":"New insights into the role of NLRP3 Inflammasome in pathogenesis and treatment of chronic obstructive pulmonary disease","volume":"14","author":"Zhang","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bioorg.2025.109209_bb0260","doi-asserted-by":"crossref","first-page":"1109938","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.109209_bb0265","doi-asserted-by":"crossref","first-page":"1006654","DOI":"10.3389\/fimmu.2022.1006654","article-title":"The NLRP3 inflammasome as a new target in respiratory disorders treatment","volume":"13","author":"Leszczy\u0144ska","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109209_bb0270","first-page":"1","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduction and Targeted Therapy 2020 5:1"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109209_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200214","article-title":"Application of automated machine learning in the identification of multi-target-directed ligands blocking PDE4B, PDE8A, and TRPA1 with potential use in the treatment of asthma and COPD","volume":"42","author":"Gawalska","year":"2023","journal-title":"Mol Inform"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109209_bb0280","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.bmcl.2015.03.031","article-title":"2-(Isopropylamino)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as selective phosphodiesterase 7 inhibitors with potent in vivo efficacy","volume":"25","author":"Endo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109209_bb0285","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neuron.2019.11.023","article-title":"Structural insights into electrophile irritant sensing by the human TRPA1 channel","volume":"105","author":"Suo","year":"2020","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109209_bb0290","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1021\/acs.jmedchem.7b00302","article-title":"Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties","volume":"60","author":"Dyck","year":"2017","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109209_bb0295","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1021\/bi049868i","article-title":"Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity","volume":"43","author":"Scapin","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.109209_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105511","article-title":"Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells \u2013 involvement of carbonyl reductase 1","volume":"154","author":"Koczurkiewicz-Adamczyk","year":"2020","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825010892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:08:01Z","timestamp":1773310081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825010892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":59,"alternative-id":["S0045206825010892"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109209","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purine-2,6-dione-based multitarget-directed ligands inhibiting PDE\/TRPA1\/CHIT1 as a new approach for the treatment of COPD","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109209"}}